Know Cancer

or
forgot password

Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service


N/A
18 Years
N/A
Open (Enrolling)
Both
Quality of Life

Thank you

Trial Information

Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service


In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility
of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS
established the Integrative Oncology Program with the goal of addressing patient concerns
and improving quality of life parameters during chemotherapy and advanced disease. The study
is purposed to assess concerns, needs and perspectives of patients referred to integrative
consultation during chemotherapy and/or advanced cancer; to characterize social demographic
and health parameters of patients who consult or avoid integrative medicine consultation; to
document complementary medicine use prior and during consultation; to assess if
complementary medicine consultation and treatment improve patient's concerns and well-being;
and to assess oncology provider and integrative practitioner communications issues
concerning integrative care.


Inclusion Criteria:



- Patients with cancer diagnosis receiving chemotherapy and/or surgical treatment who
are referred by their oncology provider to complementary medicine consultation

- Age older than 18 years

Exclusion Criteria:

- Age younger than 18 years

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire

Outcome Description:

Assessing patients'concerns and Wellbeing as well as narrative assessment of integrative care outcomes

Outcome Time Frame:

6-12 weeks(+follow-up 4 months)

Safety Issue:

No

Principal Investigator

Eran Ben-Arye, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Clalit Health Services

Authority:

Israel: Ethics Commission

Study ID:

CMC-09-0024-CTIL

NCT ID:

NCT01860365

Start Date:

July 2009

Completion Date:

September 2016

Related Keywords:

  • Quality of Life
  • Quality of life
  • Integrative medicine
  • Supportive care
  • Cancer
  • Chemotherapy

Name

Location